Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome
<b>Background:</b> Hypertriglyceridemia has serious health risks such as cardiovascular disease, type 2 diabetes mellitus, nephropathy, and others. Fenofibrate is an effective hypolipidemic drug, but its benefits for ameliorating disorders associated with hypertriglyceridemia failed to b...
Saved in:
Main Authors: | Jan Soukop, Ludmila Kazdová, Martina Hüttl, Hana Malínská, Irena Marková, Olena Oliyarnyk, Denisa Miklánková, Soňa Gurská, Zuzana Rácová, Martin Poruba, Rostislav Večeřa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/212 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of silymarin on ischemia-reperfusion injury in skeletal muscles of rats
by: Abdullah Ozer, et al.
Published: (2024-03-01) -
Silymarin: a promising modulator of apoptosis and survival signaling in cancer
by: Ujjawal Sharma, et al.
Published: (2025-01-01) -
High-performance liquid chromatography and derivative spectrophotometry for simultaneous determination of pravastatin and fenofibrate in the dosage form
by: Hefnawy Mohamed M., et al.
Published: (2014-12-01) -
Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database
by: Qun Li, et al.
Published: (2025-02-01) -
Neuroprotective Effect of Leaf Extract of Moringa Oleifera And Fenofibrate on Learning and Memory in Wistar Rats Subjected to Water Immersion Restraint Stress
by: Stephen, Olawale Ajayi, et al.
Published: (2023)